Dabin Liu

State Key Laboratory Of Digestive Disease
Hong Kong, HCW, Hong Kong Special Administrative Region

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.

SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.

Journal: EBioMedicine
Published: May 18, 2021

Squalene Epoxidase Induces Nonalcoholic Steatohepatitis Via Binding to Carbonic Anhydrase III and is a Therapeutic Target.

Squalene Epoxidase Induces Nonalcoholic Steatohepatitis Via Binding to Carbonic Anhydrase III and is a Therapeutic Target.

Journal: Gastroenterology
Published: May 07, 2020

RNA N6-Methyladenosine Methyltransferase METTL3 Facilitates Colorectal Cancer by Activating the m6A-GLUT1-mTORC1 Axis and Is a Therapeutic Target.

RNA N6-Methyladenosine Methyltransferase METTL3 Facilitates Colorectal Cancer by Activating the m6A-GLUT1-mTORC1 Axis and Is a Therapeutic Target.

Journal: Gastroenterology
Published: April 26, 2020

In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.

In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.

Journal: Gastroenterology
Published: February 25, 2020

APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.

APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.

Journal: Theranostics
Published: March 08, 2019

DEAD-box helicase 27 promotes colorectal cancer growth and metastasis and predicts poor survival in CRC patients.

DEAD-box helicase 27 promotes colorectal cancer growth and metastasis and predicts poor survival in CRC patients.

Journal: Oncogene
Published: October 26, 2017

Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target.

Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target.

Journal: Science translational medicine
Published: September 18, 2017

O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress.

O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress.

Journal: Journal of hepatology
Published: September 19, 2016

CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma.

CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma.

Journal: Oncotarget
Published: October 04, 2014
Showing 1-9 of 9

Last Updated: 09/26/2026